microRNAs (miRs)
are proposed as critical molecular targets in
SARS-CoV-2 infection. Our recent
in silico
studies
identified seven SARS-CoV-2 specific miR-like sequences, which are
highly conserved with humans, including miR-1307-3p, with critical
roles in COVID-19. In this current study, Vero cells were infected
with SARS-CoV-2, and miR expression profiles were thereafter confirmed
by qRT-PCR. miR-1307-3p was the most highly expressed miR in the infected
cells; we, therefore, transiently inhibited its expression in both
infected and uninfected cells. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) cell proliferation assay assessed cell viability
following SARS-CoV-2 infection, identifying that miR-1307 expression
is inversely correlated with cell viability. Lastly, changes in miR-1307-dependent
pathways were analyzed through a detailed miRNOME and associated
in silico
analysis. In addition to our previously identified
miRs, including miR-1307-3p, the upregulation of miR-193a-5p, miR-5100,
and miR-23a-5p and downregulation of miR-130b-5p, miR34a-5p, miR-505-3p,
miR181a-2-3p, miR-1271-5p, miR-598-3p, miR-34c-3p, and miR-129-5p
were also established in Vero cells related to general lung disease-related
genes following SARS-CoV-2 infection. Targeted anti-miR-1307-3p treatment
rescued cell viability in infection when compared to SARS CoV-2 mediated
cell cytotoxicity only. We furthermore identified by
in silico
analysis that miR-1307-3p is conserved in all SARS-CoV-2 sequences/strains,
except in the BA.2 variant, possibly contributing to the lower disease
severity of this variant, which warrants further investigation. Small
RNA seq analysis was next used to evaluate alterations in the miRNOME,
following miR-1307-3p manipulation, identifying critical pathobiological
pathways linked to SARS-CoV-2 infection-mediated upregulation of this
miR. On the basis of our findings, miRNAs like miR-1307-3p play a
critical role in SARS-CoV-2 infection, including via effects on disease
progression and severity.